About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDivi's Laboratories Limited9.58776237337.9664
Domestic EquitiesAster DM Healthcare Limited8.992070516435.6073
Domestic EquitiesRPG Life Sciences Limited7.949715052931.4801
Domestic EquitiesTorrent Pharmaceuticals Ltd7.02808377527.8301
Domestic EquitiesReliance Industries Limited6.890819421227.2868
Domestic EquitiesAlivus Life Sciences6.866724629827.1913
Domestic EquitiesAurobindo Pharma Limited6.744721730026.7083
Domestic EquitiesZydus Wellness Ltd5.721312834622.6556
Domestic EquitiesPfizer Ltd5.22864823120.7046
Domestic EquitiesSMS Pharmaceuticals Limited4.959283321319.6380
Domestic EquitiesSequent Scientific Limited4.8992134632019.4005
Domestic EquitiesHFCL Limited4.7916239000018.9742
Domestic EquitiesLupin Limited3.01525697611.9399
Domestic EquitiesSuraksha Diagnostic Limited2.570034013610.1769
Total 85.2446 337.5600
Cash & Cash Equivalents and Net AssetsTREPS 02-May-2025 DEPO 1012.35234892248.9137
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-12.6630 -50.1442
Total -0.3107 -1.2305
Treasury Bills91 Days Treasury Bill 17-Jul-20251.24715000004.9384
Total 1.2471 4.9384
Derivatives-FuturesLupin Limited 29/05/20256.458312155025.5741
Derivatives-FuturesDr. Reddy's Laboratories Limited 29/05/20254.448714812517.6165
Derivatives-FuturesAurobindo Pharma Limited 29/05/20252.91209350011.5314
Total 13.8190 54.7220
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.